FORUS Therapeutics is pleased to welcome Chris Blowes as Associate Director, Regulatory Affairs. Chris is a highly experienced pharmaceutical industry professional who has supported development and commercial teams throughout numerous product life cycles. Most recently, Chris led the Canadian submission planning and execution process for new drug products in the Regulatory Affairs department at Celgene, developing exceptional leadership and strategic skills. Previously he worked for GSK in Pharmaceutical Development before joining their Regulatory Affairs team. We are excited that Chris has chosen FORUS to continue his career and passion for bringing important therapies to patients.
News
